CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

Lucknow:  Marking 70 years of its inception, the Central Drug Research Institute (CDRI) in Lucknow launched a new and advanced research facility called Common Research and Technology Development Hub (CRTDH). As per the motive behind its establishment, this centre would be aiding hospitals and pharmaceutical sector entities in conducting clinical tests and trials. Besides, the latest hub would also facilitate MSMEs and academia with an avenue for high-level research.

The representative from CDRI was quoted saying “CRDTH is not only for scientists but for institutions conducting advanced research in the field of drug discovery. CDRI will not only provide infrastructure support like high-end laboratories and equipment but also the expertise of our scientists.”

With the cutting edge research and development projects undertaken by the CSIR-CDRI, the world has been gifted with a wide range of low-cost efficient drugs and medicines. Amongst its innovative contributions to the drug industry, the most prominent names are Centchroman, the first non-steroidal oral contraceptive and Arteether, a lifesaving drug for cerebral malaria.

In addition to being a top-notch organisation for the development and manufacturing of drugs, CDRI has worked on multiple initiatives to upgrade the quality of elementary research and strengthen human resources.

The CRTDH was inaugurated along with the launch of Atal National Colloquium on Healthcare and Innovation. As a part of this flagship program, a number of renowned and eminent personalities will hold sessions and lectures. This program has been planned to honour the erstwhile Prime Minister Atal Vihari Bajpayee’s vision, that considered scientific development, the topmost priority. This event was also marked by the announcement of the coveted CDRI Awards-2021 for Excellence in Drug Research.

Related Posts

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

Price cap on 2 key cancer drugs increased by 50%

NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

Price cap on 2 key cancer drugs increased by 50%

Price cap on 2 key cancer drugs increased by 50%

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case